The Oncosearch | Oncotarget

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970 Research Paper

Amy B. Hall, Dave Newsome, Yuxin Wang, Diane M. Boucher, Brenda Eustace, Yong Gu, Brian Hare, Mac A. Johnson, Howard Li, Sean Milton, Cheryl E. Murphy, Darin Takemoto, Crystal Tolman, Mark Wood, Peter Charlton, Jean-Damien Charrier, Brinley Furey, Julian Golec, Philip M. Reaper, John R. Pollard

Published Jul 3, 2014 · Vol. 5, No. 14 · pp. 5674-5685

Decitabine reactivated pathways in platinum resistant ovarian cancer Research Paper

Fang Fang, Qingyao Zuo, Jay Pilrose, Yinu Wang, Changyu Shen, Meng Li, Phillip Wulfridge, Daniela Matei, Kenneth P. Nephew

Published May 13, 2014 · Vol. 5, No. 11 · pp. 3579-3589

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells Research Paper

Wei Qian, Jingnan Wang, Vera Roginskaya, Lee A. McDermott, Robert P. Edwards, Donna B. Stolz, Fabien Llambi, Douglas R. Green, Bennett Van Houten

Published May 4, 2014 · Vol. 5, No. 12 · pp. 4180-4194

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells Research Paper

Young Eun Choi, Chiara Battelli, Jacqueline Watson, Joyce Liu, Jennifer Curtis, Alexander N. Morse, Ursula A. Matulonis, Dipanjan Chowdhury, Panagiotis A. Konstantinopoulos

Published Apr 30, 2014 · Vol. 5, No. 9 · pp. 2678-2687

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Vamsi K. Kolukula, Geetaram Sahu, Anton Wellstein, Olga C. Rodriguez, Anju Preet, Vito Iacobazzi, Gabriella D'Orazi, Chris Albanese, Ferdinando Palmieri, Maria Laura Avantaggiati

Published Mar 16, 2014 · Vol. 5, No. 5 · pp. 1212-1225

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition Research Paper

Qiong Wang, Shaoqing Shi, Weiyang He, Mabel T. Padilla, Lin Zhang, Xia Wang, Bin Zhang, Yong Lin

Published Feb 25, 2014 · Vol. 5, No. 5 · pp. 1304-1314

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Laura Bonanno, Carlota Costa, Margarita Majem, Jose Javier Sanchez, Ana Gimenez-Capitan, Ignacio Rodriguez, Alain Vergenegre, Bartomeu Massuti, Adolfo Favaretto, Massimo Rugge, Cinta Pallares, Miquel Taron, Rafael Rosell

Published Jul 31, 2013 · Vol. 4, No. 10 · pp. 1572-1581

Keywords: BRCA1, 53BP1, DNA repair, predictive modeling, platinum

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer Research Perspective

Helen M. Coley, Eleftheria Hatzmichael, Sarah P. Blagden, Iain A. McNeish, Alastair Thompson, Tim Crook, Nelofer Syed

Published Jan 28, 2012 · Vol. 3, No. 1 · pp. 78-83

Keywords: PLK2, drug resistance, ovarian cancer

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors Research Paper

Asfar S. Azmi, Sanjeev Banerjee, Shadan Ali, Zhiwei Wang, Bin Bao, Frances WJ Beck, Anthony F. Shields, Philip Philip, Fazlul H. Sarkar, Ramzi M. Mohammad

Published May 16, 2011 · Vol. 2, No. 5 · pp. 378-392

Keywords: p53, MDM2, MDM2 inhibitor, oxaliplatin, Systems biology, Network Modeling, Combination Synergy, Pancreatic ductal adenocarcinoma

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review

Rodrigo Dienstmann, Pablo Martinez, Enriqueta Felip

Published Mar 23, 2011 · Vol. 2, No. 3 · pp. 165-177

Keywords: ALK, EGFR, KRAS, lung cancer, targeted therapy

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970 Research Paper

Decitabine reactivated pathways in platinum resistant ovarian cancer Research Paper

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells Research Paper

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells Research Paper

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition Research Paper

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer Research Perspective

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors Research Paper

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970 Research Paper

Decitabine reactivated pathways in platinum resistant ovarian cancer Research Paper

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells Research Paper

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells Research Paper

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Priority Research Paper

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition Research Paper

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer Research Perspective

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors Research Paper

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review